Tetsuhiro Tanaka

10.1k total citations · 2 hit papers
138 papers, 6.9k citations indexed

About

Tetsuhiro Tanaka is a scholar working on Cancer Research, Molecular Biology and Nephrology. According to data from OpenAlex, Tetsuhiro Tanaka has authored 138 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cancer Research, 44 papers in Molecular Biology and 39 papers in Nephrology. Recurrent topics in Tetsuhiro Tanaka's work include Cancer, Hypoxia, and Metabolism (57 papers), Erythropoietin and Anemia Treatment (27 papers) and Chronic Kidney Disease and Diabetes (22 papers). Tetsuhiro Tanaka is often cited by papers focused on Cancer, Hypoxia, and Metabolism (57 papers), Erythropoietin and Anemia Treatment (27 papers) and Chronic Kidney Disease and Diabetes (22 papers). Tetsuhiro Tanaka collaborates with scholars based in Japan, United States and Germany. Tetsuhiro Tanaka's co-authors include Masaomi Nangaku, Reiko Inagi, Toshiro Fujita, Imari Mimura, Toshio Miyata, Takamoto Ohse, Shinji Tanaka, Mai Sugahara, Julie R. Ingelfinger and Ichiro Kojima and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Tetsuhiro Tanaka

134 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury

2019 419 citations Hiroshi Nishi, Tetsuhiro Tanaka et al. profile →
Treatment of Diabetic Kidney Disease: Current and Future

2021 169 citations Imari Mimura, Tetsuhiro Tanaka et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsuhiro Tanaka Japan	47	2.5k	2.1k	1.7k	1.1k	711	138	6.9k
María Dolores Sánchez-Niño Spain	53	3.0k 1.2×	2.9k 1.4×	1.0k 0.6×	268 0.2×	821 1.2×	173	8.2k
Guangyan Cai China	45	2.2k 0.9×	2.3k 1.1×	588 0.3×	297 0.3×	716 1.0×	338	6.8k
Lin Sun China	50	4.3k 1.7×	2.8k 1.3×	1.1k 0.6×	181 0.2×	1.1k 1.5×	207	9.6k
David A. Power Australia	44	2.4k 1.0×	1.5k 0.7×	411 0.2×	554 0.5×	1.1k 1.5×	187	7.0k
Chunsun Dai China	52	4.1k 1.7×	2.8k 1.3×	797 0.5×	209 0.2×	1.2k 1.7×	119	8.0k
Naoki Kashihara Japan	42	1.7k 0.7×	2.1k 1.0×	299 0.2×	353 0.3×	868 1.2×	251	6.2k
Leon J. Schurgers Netherlands	70	2.6k 1.0×	5.1k 2.4×	727 0.4×	534 0.5×	1.8k 2.5×	283	15.7k
Sergey V. Brodsky United States	47	2.2k 0.9×	1.7k 0.8×	439 0.3×	355 0.3×	1.0k 1.4×	146	7.0k
Fuyou Liu China	40	2.6k 1.0×	2.3k 1.1×	602 0.4×	209 0.2×	693 1.0×	206	6.2k
Chuan‐Ming Hao China	43	2.2k 0.9×	1.6k 0.8×	404 0.2×	216 0.2×	702 1.0×	186	6.9k

Countries citing papers authored by Tetsuhiro Tanaka

Since Specialization

Citations

This map shows the geographic impact of Tetsuhiro Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhiro Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhiro Tanaka more than expected).

Fields of papers citing papers by Tetsuhiro Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuhiro Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhiro Tanaka. The network helps show where Tetsuhiro Tanaka may publish in the future.

Co-authorship network of co-authors of Tetsuhiro Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuhiro Tanaka. A scholar is included among the top collaborators of Tetsuhiro Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuhiro Tanaka. Tetsuhiro Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kojima, Kaname, Silvia Malvica, Kenshi Yamasaki, et al.. (2025). Deep learning-based histopathological assessment of tubulo-interstitial injury in chronic kidney diseases. Communications Medicine. 5(1). 3–3. 2 indexed citations

Oe, Yuji, Yuji Noguchi, Kôichi Kikuchi, et al.. (2025). Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma Developing Renal AA Amyloidosis: A Case Report and Literature Review. Internal Medicine. 64(8). 1199–1204.

Oe, Yuji, Tetsuhiro Tanaka, & Nobuyuki Takahashi. (2025). The Many Faces of Protease-Activated Receptor 2 in Kidney Injury. Biomedicines. 13(2). 414–414. 1 indexed citations

Tanaka, Tetsuhiro, et al.. (2024). Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database study. Scientific Reports. 14(1). 5172–5172. 9 indexed citations

Maruyama, Shoichi, et al.. (2024). Cardiovascular, renal and mortality risk by the KDIGO heatmap in Japan. Clinical Kidney Journal. 17(8). sfae228–sfae228. 2 indexed citations

Ono, Yoshikiyo, Yuta Tezuka, Kei Omata, et al.. (2024). Screening Cutoff Values for the Detection of Aldosterone-Producing Adenoma by LC-MS/MS and a Novel Noncompetitive CLEIA. Journal of the Endocrine Society. 8(6). bvae080–bvae080. 5 indexed citations

Yamazaki, Tomohide, Hiroko Sato, Tsuyoshi Shirai, et al.. (2023). Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet + B cells in systemic lupus erythematosus. Arthritis Research & Therapy. 25(1). 200–200. 7 indexed citations

Kimura, Hiroshi, Soo Hyeon Kim, Shohei Kaneda, et al.. (2022). Enhanced podocyte differentiation and changing drug toxicity sensitivity through pressure-controlled mechanical filtration stress on a glomerulus-on-a-chip. Lab on a Chip. 23(3). 437–450. 19 indexed citations

Kashiwabara, Kosuke, Yosuke Hirakawa, Tetsuhiro Tanaka, et al.. (2020). Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diabetes Research & Care. 8(1). e000902–e000902. 36 indexed citations

10.

Tanaka, Tetsuhiro & Kai‐Uwe Eckardt. (2018). HIF Activation Against CVD in CKD: Novel Treatment Opportunities. Seminars in Nephrology. 38(3). 267–276. 31 indexed citations

11.

Hirakawa, Yosuke, Toshitada Yoshihara, Ippei Takahashi, et al.. (2018). Intravital phosphorescence lifetime imaging of the renal cortex accurately measures renal hypoxia. Kidney International. 93(6). 1483–1489. 28 indexed citations

12.

Jardine, Meg, Bertram L. Kasiske, Dwomoa Adu, et al.. (2017). Closing the gap between evidence and practice in chronic kidney disease. Kidney International Supplements. 7(2). 114–121. 11 indexed citations

13.

Chiang, Chih‐Kang, Masaomi Nangaku, Tetsuhiro Tanaka, Takao Iwawaki, & Reiko Inagi. (2012). Endoplasmic reticulum stress signal impairs erythropoietin production: a role for ATF4. American Journal of Physiology-Cell Physiology. 304(4). C342–C353. 38 indexed citations

14.

Tanaka, Tetsuhiro & Masaomi Nangaku. (2011). Pathogenesis of Tubular Interstitial Nephritis. Contributions to nephrology. 169. 297–310. 11 indexed citations

15.

Kojima, Ichiro, Tetsuhiro Tanaka, Reiko Inagi, et al.. (2009). Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidney. Kidney International. 75(3). 268–277. 44 indexed citations

16.

Kojima, Ichiro, Tetsuhiro Tanaka, Reiko Inagi, et al.. (2007). Protective Role of Hypoxia-Inducible Factor-2α against Ischemic Damage and Oxidative Stress in the Kidney. Journal of the American Society of Nephrology. 18(4). 1218–1226. 111 indexed citations

17.

Kojima, Ichiro, et al.. (2006). Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase. Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery). 1(2). 129–139. 27 indexed citations

18.

Tanaka, Tetsuhiro, Makiko Matsumoto, Reiko Inagi, et al.. (2005). Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis. Kidney International. 68(6). 2714–2725. 105 indexed citations

19.

Tanaka, Tetsuhiro, Toshio Miyata, Reiko Inagi, Toshiro Fujita, & Masaomi Nangaku. (2004). Hypoxia in Renal Disease with Proteinuria and/or Glomerular Hypertension. American Journal Of Pathology. 165(6). 1979–1992. 86 indexed citations

20.

Manotham, Krissanapong, Tetsuhiro Tanaka, Makiko Matsumoto, et al.. (2004). Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney International. 65(3). 871–880. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact